FDA Adverse Event Death Summary report: N

PENUMBRA SYSTEM REPERFUSION CATHETER 054

MDR report key: 2502518 · Received March 23, 2012

Report

Report Number
3005168196-2012-00107
Event Type
Death
Date Received
March 23, 2012
Date of Event
February 19, 2012
Report Date
February 28, 2012
Manufacturer
PENUMBRA, INC.
Product Code
NRY
PMA / PMN Number
K090752
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCLUSION: EMBOLI IS A KNOWN AND ANTICIPATED COMPLICATION WITH THESE TYPES OF PROCEDURES AND IS NOTED IN THE DEVICE LABELING. THEREFORE, IT WAS DETERMINED THAT THE REPORTED EVENT WAS AN ANTICIPATED PROCEDURAL COMPLICATION. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, QUALITY, OR DESIGN CONCERNS. DEVICE DISCARDED BY THE HOSPITAL.

Description of Event or Problem · 1

THE REPERFUSION CATHETER 054 WAS USED TO ASPIRATE CLOTS N THE C2 SEGMENT OF THE LEFT INTERNAL CAROTID ARTERY (ICA). AFTER THE C2 WAS OPENED, ADDITIONAL EMBOLI CAUSED REOCCLUSION. A BALLOON PTA PROCEDURE WAS USED TO REOPEN THE C2 BUT IT OCCLUDED AGAIN. A STENT WAS PLACED WITH PTA AT THE C2 SEGMENT BUT STILL THE OCCLUSION REMAINED. THE PHYSICIAN DECIDED TO END THE PROCEDURE. THE PHYSICIAN NOTED ATHEROSCLEROTIC PLAQUE AT THE SITE OF THE LESION WHICH CAUSED THE EMBOLI. HE WAS NOT SURE WHICH DEVICE CAUSED RUPTURE OF THE PLAQUE AND THE RELEASE OF DISTAL EMBOLI. INTRAVENOUS OZAGREL WAS ADMINISTERED TO THE PATIENT AFTER TREATMENT. THE PATIENT DIED ON (B)(6) 2012. THE PHYSICIAN COMMENTED THAT ADDITIONAL TREATMENTS COULD NOT HAVE PREVENTED THE REOCCLUSION. THE PATIENT WAS CONTRAINDICATED FOR T-PA; THEREFORE, IT WAS NOT ADMINISTERED; HOWEVER, IT WAS NOTED THAT IT MIGHT HAVE LEAD TO A DIFFERENCE IN THE OUTCOME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PENUMBRA SYSTEM REPERFUSION CATHETER 054 NRY NRY PENUMBRA, INC. F23249

Patients

Seq Age Sex Outcome Treatment
1 62 YR Death| O